<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="226">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04709744</url>
  </required_header>
  <id_info>
    <org_study_id>RP.21.01.91</org_study_id>
    <nct_id>NCT04709744</nct_id>
  </id_info>
  <brief_title>Impact of Vitamin D Level and Supplement on SLE Patients During COVID-19 Pandemic</brief_title>
  <official_title>Impact of Vitamin D Level and Supplement on SLE Patients During COVID-19 Pandemic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of the work Impact of serum vit D level in SLE patients with COVID-19 disease on severity&#xD;
      of infection, duration of COVID-19 disease course, fatigue development as a complication for&#xD;
      both SLE and COVID-19 and assess impact of prior chloroquine on COVID-19 disease outcomes&#xD;
      Patients and methods 38 SLE patients previously diagnosed and on different lines of lupus&#xD;
      management. Participants were presented to chest outpatient clinic and emergency hospital,&#xD;
      Mansoura University with manifestation suggesting COVID-19 infection. Serum vit D was&#xD;
      measured in serum by ELISA.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary objective: assess the impact of serum vit D level in SLE patients with COVID-19&#xD;
      disease on severity of infection and pandemic treatment outcome.&#xD;
&#xD;
      Secondary objectives:&#xD;
&#xD;
        -  Effect of serum vit D level in SLE patients on duration of COVID-19 disease course and&#xD;
           fatigue development as a complication for both SLE and COVID-19&#xD;
&#xD;
        -  Impact of prior chloroquine on COVID-19 disease outcomes&#xD;
&#xD;
        -  Correlation of serum vit D level with different laboratory investigations at time of&#xD;
           COVID-19 outbreak&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2020</start_date>
  <completion_date type="Actual">December 30, 2020</completion_date>
  <primary_completion_date type="Actual">December 25, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Level of serum vitamin D in SLE infected with COVID-19</measure>
    <time_frame>6 months</time_frame>
    <description>Measurement of serum vit D level (ng/ml)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vitamin D level with COVID-19 severity</measure>
    <time_frame>6 months</time_frame>
    <description>Level of serum vitamin D (ng/ml) in mild, moderate and sever COVID-19</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Impact of serum vit D level in SLE patients on duration of COVID-19 disease course</measure>
    <time_frame>6 months</time_frame>
    <description>serum vit D level (ng/ml) in SLE patients and time to recovery (number of days) from COVID-19</description>
  </other_outcome>
  <other_outcome>
    <measure>Impact of prior chloroquine on COVID-19 disease outcomes</measure>
    <time_frame>6 months</time_frame>
    <description>Can prior chloroquine in SLE patients affect outcome of COVID-19 infection (recovery or die)</description>
  </other_outcome>
  <other_outcome>
    <measure>Serum vitamin D level and development of fatigue</measure>
    <time_frame>6 months</time_frame>
    <description>Basal vitamin d level (ng/ml) in SLE patients diagnosed with recent COVID-19 and development of fatigue after recovery from COVID-19 infection</description>
  </other_outcome>
  <other_outcome>
    <measure>Correlation of serum vit D level with different laboratory investigations at time of COVID-19 outbreak</measure>
    <time_frame>6 months</time_frame>
    <description>Correlation of serum vit D level (ng/ml) with ESR, CRP, serum Lymphocyte count, Ferritine, D-dimer at time of COVID-19 diagnosis</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">38</enrollment>
  <condition>Covid19</condition>
  <arm_group>
    <arm_group_label>SLE patients</arm_group_label>
    <description>SLE patients were presented to chest outpatient clinic and emergency hospital, Mansoura University with manifestation suggesting COVID-19 infection. Vit D was measured in serum by ELISA. Vit D was added to anti COVID-19.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D</intervention_name>
    <description>Impact of serum vit D level in SLE patients with COVID-19 disease on severity of infection, duration of COVID-19 disease course, fatigue development as a complication for both SLE and COVID-19 and assess impact of prior chloroquine on COVID-19 disease outcomes</description>
    <arm_group_label>SLE patients</arm_group_label>
    <other_name>Serum Vitamin D level</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>ELISA</intervention_name>
    <description>Measure vitamin D level</description>
    <arm_group_label>SLE patients</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum sample for Vitamin D level by ELISA&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        SLE patients infected with COVID-19&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  - SLE patients previously diagnosed&#xD;
&#xD;
          -  Patients are not suffering from malignancies.&#xD;
&#xD;
          -  Patients have no organ failure nor uncontrolled medical illness.&#xD;
&#xD;
          -  Recent COVID-19 infection&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  - Pregnant, lactating females&#xD;
&#xD;
          -  Concurrent malignancies&#xD;
&#xD;
          -  Patients with other autoimmune disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>yasmin ElbaiomyAdel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mansoura University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mansoura University Hospital</name>
      <address>
        <city>Mansoura</city>
        <state>DK</state>
        <zip>35516</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 9, 2021</study_first_submitted>
  <study_first_submitted_qc>January 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 14, 2021</study_first_posted>
  <last_update_submitted>January 13, 2021</last_update_submitted>
  <last_update_submitted_qc>January 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Yasmin Adel Abdelsalam Hussein</investigator_full_name>
    <investigator_title>Lecturer of Rheumatology and Rehabilitation</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

